Cargando…

S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability

Here, we show for the first time that the familial breast/ovarian cancer susceptibility gene, BRCA1, along with interacting ΔNp63 proteins, transcriptionally upregulate the putative tumour suppressor protein, S100A2. Both BRCA1 and ΔNp63 proteins are required for S100A2 expression. BRCA1 requires ΔN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, N E, D'Costa, Z, Kaminska, M, Mullan, P B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944248/ https://www.ncbi.nlm.nih.gov/pubmed/24556685 http://dx.doi.org/10.1038/cddis.2014.31

Ejemplares similares

Identification of signalling pathways downstream of BRCA1 and p63
por: Crawford, N, et al.
Publicado: (2010)

Analysis of the DNA Binding Activity of BRCA1 and Its Modulation by the Tumour Suppressor p53
por: Naseem, Riffat, et al.
Publicado: (2008)

Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins
por: Pagano, Bruno, et al.
Publicado: (2013)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
por: Boominathan, Lakshmanane
Publicado: (2010)

Functional interplay between MDM2, p63/p73 and mutant p53
por: Stindt, M H, et al.
Publicado: (2015)

BRCA1 and p53 Tumor Suppressor Molecules in Alzheimer’s Disease
por: Nakanishi, Atsuko, et al.
Publicado: (2015)

Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
por: Silva, Jerson L., et al.
Publicado: (2013)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Coregulation of FANCA and BRCA1 in human cells
por: Haitjema, Anneke, et al.
Publicado: (2014)

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
por: Na, Bing, et al.
Publicado: (2019)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63
por: Martynova, Elena, et al.
Publicado: (2012)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
por: Kaypee, Stephanie, et al.
Publicado: (2018)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

p53, p63 and p73 in the wonderland of S. cerevisiae
por: Billant, Olivier, et al.
Publicado: (2017)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype
por: Muller, Patricia A. J., et al.
Publicado: (2014)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
por: Barton, C. M., et al.
Publicado: (1991)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
Publicado: (1992)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
por: Haupt, Sue, et al.
Publicado: (2021)

Tumour Suppressor Mechanisms in the Control of Chromosome Stability: Insights from BRCA2
por: Venkitaraman, Ashok R.
Publicado: (2014)

Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.
por: Brown, J. M.
Publicado: (1998)

P63 and P73 Activation in Cancers with p53 Mutation
por: Cai, Bi-He, et al.
Publicado: (2022)

The Role of Mutant p63 in Female Fertility
por: Luan, Yi, et al.
Publicado: (2021)

p63 and p53: Collaborative Partners or Dueling Rivals?
por: Woodstock, Dana L., et al.
Publicado: (2021)

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
por: Slatter, T L, et al.
Publicado: (2015)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site
por: Kirschner, Ralf D., et al.
Publicado: (2008)

Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA
por: Veprintsev, Dmitry B., et al.
Publicado: (2008)

Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53
por: Petrovich, Miriana, et al.
Publicado: (2009)

Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53
por: Wang, Junbai, et al.
Publicado: (2010)

Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
por: Lieschke, Elizabeth, et al.
Publicado: (2018)

The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
por: Armstrong, Stephen R., et al.
Publicado: (2016)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_25adfa3g79mgka6v2tda5meigd